Portugal patients take part in personalised melanoma vaccine trial

Three patients being treated at the Portuguese Institute of Oncology (IPO) in Lisbon are among those taking part in an international clinical trial testing a personalised vaccine for melanoma, one of the most aggressive forms of skin cancer.